Optimi Health Corp. Common Shares is trading at $4.51 (8.2% down) as it extends a sharp pullback following its recent ibogaine drug-development announcement and subsequent profit-taking.
- The stock has faced significant volatility, including a 10.1% drop as investors cashed out following a major rally triggered by the ibogaine news.
- A weak broader market tone is adding further downward pressure on the stock during pre-market trading.